ClinicalTrials.Veeva

Menu

Comparison of the Effects of Crystalloid Cardioplegia and HTK Solution for Postoperative Troponin-I and CK-MB Levels After Pediatric Cardiac Surgery

B

Baskent University

Status and phase

Unknown
Phase 4

Conditions

Myocardial Injury

Treatments

Drug: crystalloid cardioplegia solution
Drug: HTK solution

Study type

Interventional

Funder types

Other

Identifiers

NCT01548872
KA/11-152

Details and patient eligibility

About

The purpose of this study is to compare two different cardioplegia solutions effect on postoperative Troponin-I and CK-MB levels after pediatric cardiac surgery.

Enrollment

60 estimated patients

Sex

All

Ages

1 month to 6 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients scheduled for elective pediatric cardiac surgery
  • Patients written informed consent for study participation

Exclusion criteria

  • redo surgery
  • allergy to study drugs
  • unstable blood pressure before cardiac surgery

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

60 participants in 2 patient groups

crystalloid cardioplegia solution
Active Comparator group
Description:
After aortic cross clamp 30ml/kg will be administered
Treatment:
Drug: crystalloid cardioplegia solution
HTK solution
Active Comparator group
Description:
After aortic cross clamp 50ml/kg will be administered
Treatment:
Drug: HTK solution

Trial contacts and locations

1

Loading...

Central trial contact

Selim Kuşlu; Pınar Zeyneloğlu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems